Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017
•We evaluated HPV vaccination in 2017 among 10,381 U.S. men who have sex with men.•17.9% of all MSM and 32.8% of MSM aged 18–26 reported receiving ≥ 1 HPV vaccine.•Coverage among MSM aged 18─26 doubled since 2014 and was six-fold higher than 2011.•Most MSM aged 18─26 were not vaccinated against HPV,...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2020-11, Vol.38 (47), p.7417-7421 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 7421 |
|---|---|
| container_issue | 47 |
| container_start_page | 7417 |
| container_title | Vaccine |
| container_volume | 38 |
| creator | McClung, Nancy Burnett, Janet Wejnert, Cyprian Markowitz, Lauri E. Meites, Elissa |
| description | •We evaluated HPV vaccination in 2017 among 10,381 U.S. men who have sex with men.•17.9% of all MSM and 32.8% of MSM aged 18–26 reported receiving ≥ 1 HPV vaccine.•Coverage among MSM aged 18─26 doubled since 2014 and was six-fold higher than 2011.•Most MSM aged 18─26 were not vaccinated against HPV, even those living with HIV.
Men who have sex with men (MSM) are at high risk for infections and diseases caused by human papillomavirus (HPV), many of which are vaccine-preventable. In the United States, routine HPV vaccination has been recommended for adolescent males since 2011. This analysis evaluated self-reported receipt of ≥ 1 HPV vaccine dose by age group and HIV status among adult MSM using 2017 data from National HIV Behavioral Surveillance (NHBS) and compared the proportion vaccinated to prior years. Among 10,381 MSM aged ≥ 18 years, 17.9% of MSM overall and 28.4% of MSM living with HIV reported any HPV vaccination. Among 2,482 MSM aged 18–26 years, 32.8% overall and 51.3% living with HIV reported HPV vaccination. Since 2011, the proportion of MSM aged 18–26 years reporting HPV vaccination has increased over six-fold. As vaccinated adolescents age into young adults, coverage will continue to increase overall, including among MSM. |
| doi_str_mv | 10.1016/j.vaccine.2020.08.040 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2450669255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X20310811</els_id><sourcerecordid>2450669255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-8f2e74dfccaaf6d7a9c1b2327c4184d9ff2a9f56b8dee0229b2b25517a4938803</originalsourceid><addsrcrecordid>eNqFkcFu1DAURS0EotPCJ4AssWHRhGc7ceIVgqowlSpYlCJ2luO8dDyaxFM7SWHHhj_gC_kSPJ2BBRtWlq1zr-13CHnGIGfA5Kt1Phtr3YA5Bw451DkU8IAsWF2JjJesfkgWwGWRFQy-HJHjGNcAUAqmHpMjIaCQXMoF-bGcejPQrdm6zcb3ZnZhinRfbUbnB2r9jMHcIDW9H25ojwO9W3m6MjPSiF_pnRtXu9Nf339-uE-YDV1efKZvMSHOh7S9msKMqd8MFk_p9eBGbOnVaEaMp5QDq56QR53ZRHx6WE_I9bvzT2fL7PLj-4uzN5eZFUqMWd1xrIq2s9aYTraVUZY1XPDKFqwuWtV13KiulE3dIgLnquENL0tWmUKJugZxQl7ue7fB304YR927aHH3MvRT1LwoQUqVMgl98Q-69lNIn7unhKoqUDJR5Z6ywccYsNPb4HoTvmkGeudJr_XBk9550lDr5Cnlnh_ap6bH9m_qj5gEvN4DmMYxOww6Wodpfq0LaEfdevefK34DoV-oDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2453977096</pqid></control><display><type>article</type><title>Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>McClung, Nancy ; Burnett, Janet ; Wejnert, Cyprian ; Markowitz, Lauri E. ; Meites, Elissa</creator><creatorcontrib>McClung, Nancy ; Burnett, Janet ; Wejnert, Cyprian ; Markowitz, Lauri E. ; Meites, Elissa ; for the NHBS Study Group ; NHBS Study Group</creatorcontrib><description>•We evaluated HPV vaccination in 2017 among 10,381 U.S. men who have sex with men.•17.9% of all MSM and 32.8% of MSM aged 18–26 reported receiving ≥ 1 HPV vaccine.•Coverage among MSM aged 18─26 doubled since 2014 and was six-fold higher than 2011.•Most MSM aged 18─26 were not vaccinated against HPV, even those living with HIV.
Men who have sex with men (MSM) are at high risk for infections and diseases caused by human papillomavirus (HPV), many of which are vaccine-preventable. In the United States, routine HPV vaccination has been recommended for adolescent males since 2011. This analysis evaluated self-reported receipt of ≥ 1 HPV vaccine dose by age group and HIV status among adult MSM using 2017 data from National HIV Behavioral Surveillance (NHBS) and compared the proportion vaccinated to prior years. Among 10,381 MSM aged ≥ 18 years, 17.9% of MSM overall and 28.4% of MSM living with HIV reported any HPV vaccination. Among 2,482 MSM aged 18–26 years, 32.8% overall and 51.3% living with HIV reported HPV vaccination. Since 2011, the proportion of MSM aged 18–26 years reporting HPV vaccination has increased over six-fold. As vaccinated adolescents age into young adults, coverage will continue to increase overall, including among MSM.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2020.08.040</identifier><identifier>PMID: 33046266</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Acquired immune deficiency syndrome ; Adolescent ; Adolescents ; Adult ; Age groups ; AIDS ; Alphapapillomavirus ; Behavior ; Education ; Gays & lesbians ; Health care ; Health insurance ; Hispanic Americans ; HIV ; HIV Infections - epidemiology ; HIV Infections - prevention & control ; Homosexuality, Male ; Human immunodeficiency virus ; Human papillomavirus ; Humans ; Immunization ; Infections ; Insurance coverage ; Male ; Males ; Medical tests ; Mens health ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - prevention & control ; Papillomavirus Vaccines ; Sexual and Gender Minorities ; Sexually transmitted diseases ; STD ; Surveillance ; United States - epidemiology ; Vaccination ; Vaccination Coverage ; Vaccines ; Young Adult ; Young adults</subject><ispartof>Vaccine, 2020-11, Vol.38 (47), p.7417-7421</ispartof><rights>2020</rights><rights>Published by Elsevier Ltd.</rights><rights>Copyright Elsevier Limited Nov 3, 2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-8f2e74dfccaaf6d7a9c1b2327c4184d9ff2a9f56b8dee0229b2b25517a4938803</citedby><cites>FETCH-LOGICAL-c393t-8f2e74dfccaaf6d7a9c1b2327c4184d9ff2a9f56b8dee0229b2b25517a4938803</cites><orcidid>0000-0002-0077-2591</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X20310811$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33046266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McClung, Nancy</creatorcontrib><creatorcontrib>Burnett, Janet</creatorcontrib><creatorcontrib>Wejnert, Cyprian</creatorcontrib><creatorcontrib>Markowitz, Lauri E.</creatorcontrib><creatorcontrib>Meites, Elissa</creatorcontrib><creatorcontrib>for the NHBS Study Group</creatorcontrib><creatorcontrib>NHBS Study Group</creatorcontrib><title>Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>•We evaluated HPV vaccination in 2017 among 10,381 U.S. men who have sex with men.•17.9% of all MSM and 32.8% of MSM aged 18–26 reported receiving ≥ 1 HPV vaccine.•Coverage among MSM aged 18─26 doubled since 2014 and was six-fold higher than 2011.•Most MSM aged 18─26 were not vaccinated against HPV, even those living with HIV.
Men who have sex with men (MSM) are at high risk for infections and diseases caused by human papillomavirus (HPV), many of which are vaccine-preventable. In the United States, routine HPV vaccination has been recommended for adolescent males since 2011. This analysis evaluated self-reported receipt of ≥ 1 HPV vaccine dose by age group and HIV status among adult MSM using 2017 data from National HIV Behavioral Surveillance (NHBS) and compared the proportion vaccinated to prior years. Among 10,381 MSM aged ≥ 18 years, 17.9% of MSM overall and 28.4% of MSM living with HIV reported any HPV vaccination. Among 2,482 MSM aged 18–26 years, 32.8% overall and 51.3% living with HIV reported HPV vaccination. Since 2011, the proportion of MSM aged 18–26 years reporting HPV vaccination has increased over six-fold. As vaccinated adolescents age into young adults, coverage will continue to increase overall, including among MSM.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adolescent</subject><subject>Adolescents</subject><subject>Adult</subject><subject>Age groups</subject><subject>AIDS</subject><subject>Alphapapillomavirus</subject><subject>Behavior</subject><subject>Education</subject><subject>Gays & lesbians</subject><subject>Health care</subject><subject>Health insurance</subject><subject>Hispanic Americans</subject><subject>HIV</subject><subject>HIV Infections - epidemiology</subject><subject>HIV Infections - prevention & control</subject><subject>Homosexuality, Male</subject><subject>Human immunodeficiency virus</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infections</subject><subject>Insurance coverage</subject><subject>Male</subject><subject>Males</subject><subject>Medical tests</subject><subject>Mens health</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - prevention & control</subject><subject>Papillomavirus Vaccines</subject><subject>Sexual and Gender Minorities</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Surveillance</subject><subject>United States - epidemiology</subject><subject>Vaccination</subject><subject>Vaccination Coverage</subject><subject>Vaccines</subject><subject>Young Adult</subject><subject>Young adults</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkcFu1DAURS0EotPCJ4AssWHRhGc7ceIVgqowlSpYlCJ2luO8dDyaxFM7SWHHhj_gC_kSPJ2BBRtWlq1zr-13CHnGIGfA5Kt1Phtr3YA5Bw451DkU8IAsWF2JjJesfkgWwGWRFQy-HJHjGNcAUAqmHpMjIaCQXMoF-bGcejPQrdm6zcb3ZnZhinRfbUbnB2r9jMHcIDW9H25ojwO9W3m6MjPSiF_pnRtXu9Nf339-uE-YDV1efKZvMSHOh7S9msKMqd8MFk_p9eBGbOnVaEaMp5QDq56QR53ZRHx6WE_I9bvzT2fL7PLj-4uzN5eZFUqMWd1xrIq2s9aYTraVUZY1XPDKFqwuWtV13KiulE3dIgLnquENL0tWmUKJugZxQl7ue7fB304YR927aHH3MvRT1LwoQUqVMgl98Q-69lNIn7unhKoqUDJR5Z6ywccYsNPb4HoTvmkGeudJr_XBk9550lDr5Cnlnh_ap6bH9m_qj5gEvN4DmMYxOww6Wodpfq0LaEfdevefK34DoV-oDA</recordid><startdate>20201103</startdate><enddate>20201103</enddate><creator>McClung, Nancy</creator><creator>Burnett, Janet</creator><creator>Wejnert, Cyprian</creator><creator>Markowitz, Lauri E.</creator><creator>Meites, Elissa</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0077-2591</orcidid></search><sort><creationdate>20201103</creationdate><title>Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017</title><author>McClung, Nancy ; Burnett, Janet ; Wejnert, Cyprian ; Markowitz, Lauri E. ; Meites, Elissa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-8f2e74dfccaaf6d7a9c1b2327c4184d9ff2a9f56b8dee0229b2b25517a4938803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adolescent</topic><topic>Adolescents</topic><topic>Adult</topic><topic>Age groups</topic><topic>AIDS</topic><topic>Alphapapillomavirus</topic><topic>Behavior</topic><topic>Education</topic><topic>Gays & lesbians</topic><topic>Health care</topic><topic>Health insurance</topic><topic>Hispanic Americans</topic><topic>HIV</topic><topic>HIV Infections - epidemiology</topic><topic>HIV Infections - prevention & control</topic><topic>Homosexuality, Male</topic><topic>Human immunodeficiency virus</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infections</topic><topic>Insurance coverage</topic><topic>Male</topic><topic>Males</topic><topic>Medical tests</topic><topic>Mens health</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - prevention & control</topic><topic>Papillomavirus Vaccines</topic><topic>Sexual and Gender Minorities</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Surveillance</topic><topic>United States - epidemiology</topic><topic>Vaccination</topic><topic>Vaccination Coverage</topic><topic>Vaccines</topic><topic>Young Adult</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McClung, Nancy</creatorcontrib><creatorcontrib>Burnett, Janet</creatorcontrib><creatorcontrib>Wejnert, Cyprian</creatorcontrib><creatorcontrib>Markowitz, Lauri E.</creatorcontrib><creatorcontrib>Meites, Elissa</creatorcontrib><creatorcontrib>for the NHBS Study Group</creatorcontrib><creatorcontrib>NHBS Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McClung, Nancy</au><au>Burnett, Janet</au><au>Wejnert, Cyprian</au><au>Markowitz, Lauri E.</au><au>Meites, Elissa</au><aucorp>for the NHBS Study Group</aucorp><aucorp>NHBS Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2020-11-03</date><risdate>2020</risdate><volume>38</volume><issue>47</issue><spage>7417</spage><epage>7421</epage><pages>7417-7421</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>•We evaluated HPV vaccination in 2017 among 10,381 U.S. men who have sex with men.•17.9% of all MSM and 32.8% of MSM aged 18–26 reported receiving ≥ 1 HPV vaccine.•Coverage among MSM aged 18─26 doubled since 2014 and was six-fold higher than 2011.•Most MSM aged 18─26 were not vaccinated against HPV, even those living with HIV.
Men who have sex with men (MSM) are at high risk for infections and diseases caused by human papillomavirus (HPV), many of which are vaccine-preventable. In the United States, routine HPV vaccination has been recommended for adolescent males since 2011. This analysis evaluated self-reported receipt of ≥ 1 HPV vaccine dose by age group and HIV status among adult MSM using 2017 data from National HIV Behavioral Surveillance (NHBS) and compared the proportion vaccinated to prior years. Among 10,381 MSM aged ≥ 18 years, 17.9% of MSM overall and 28.4% of MSM living with HIV reported any HPV vaccination. Among 2,482 MSM aged 18–26 years, 32.8% overall and 51.3% living with HIV reported HPV vaccination. Since 2011, the proportion of MSM aged 18–26 years reporting HPV vaccination has increased over six-fold. As vaccinated adolescents age into young adults, coverage will continue to increase overall, including among MSM.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>33046266</pmid><doi>10.1016/j.vaccine.2020.08.040</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-0077-2591</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2020-11, Vol.38 (47), p.7417-7421 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2450669255 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Acquired immune deficiency syndrome Adolescent Adolescents Adult Age groups AIDS Alphapapillomavirus Behavior Education Gays & lesbians Health care Health insurance Hispanic Americans HIV HIV Infections - epidemiology HIV Infections - prevention & control Homosexuality, Male Human immunodeficiency virus Human papillomavirus Humans Immunization Infections Insurance coverage Male Males Medical tests Mens health Papillomavirus Infections - epidemiology Papillomavirus Infections - prevention & control Papillomavirus Vaccines Sexual and Gender Minorities Sexually transmitted diseases STD Surveillance United States - epidemiology Vaccination Vaccination Coverage Vaccines Young Adult Young adults |
| title | Human papillomavirus vaccination coverage among men who have sex with men—National HIV Behavioral Surveillance, United States, 2017 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T11%3A19%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20papillomavirus%20vaccination%20coverage%20among%20men%20who%20have%20sex%20with%20men%E2%80%94National%20HIV%20Behavioral%20Surveillance,%20United%20States,%202017&rft.jtitle=Vaccine&rft.au=McClung,%20Nancy&rft.aucorp=for%20the%20NHBS%20Study%20Group&rft.date=2020-11-03&rft.volume=38&rft.issue=47&rft.spage=7417&rft.epage=7421&rft.pages=7417-7421&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2020.08.040&rft_dat=%3Cproquest_cross%3E2450669255%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2453977096&rft_id=info:pmid/33046266&rft_els_id=S0264410X20310811&rfr_iscdi=true |